Skip to main content
OpenTrials

Clinical trial condition

BRCA 1 /2 and / or HRD

Explore clinical trials studying BRCA 1 /2 and / or HRD. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

BRCA 1 /2 and / or HRD trial results

Completed

Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency

NCT02789332

Conditions
BRCA 1 /2 and / or HRD, Breast Cancer, Breast Diseases, +8 more
Locations
  • Kliniken Esslingen, Gynäkologie Onkologie Esslingen am Neckar, Baden-Wurttemberg, Germany
  • Universitätsklinikum Erlangen Erlangen, Bavaria, Germany
  • Onkologisches Zentrum am Rotkreuzklinikum München München, Bavaria, Germany
  • Elisabeth Krankenhaus Kassel, Hesse, Germany
View Trial Details

Related conditions